FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/10/074797 [Registered on: 07/10/2024] Trial Registered Prospectively
Last Modified On: 20/10/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   “A study comparing post surgery outcomes in two types of breast implants used in reconstruction after a mastectomy: one placed above the chest muscle (prepectoral) and one placed below the chest muscle (subpectoral)” 
Scientific Title of Study   An open-label, parallel-group randomized controlled trial comparing post-mastectomy prepectoral and subpectoral implant based breast reconstruction in breast cancer patients 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Gajendra Pandit 
Designation  SENIOR RESIDENT  
Affiliation  AIIMS 
Address  1st Floor,Department of surgical onclogy, BRAIRCH-AIIMS, Ansari Nagar

South
DELHI
110049
India 
Phone  9471166594  
Fax    
Email  gpandit113@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR ASHUTOSH MISHRA 
Designation  Associate Professor 
Affiliation  BRAIRCH AIIMS, New Delhi 
Address  Room no.244, 2nd Floor, Department of surgical onclogy, BRAIRCH-AIIMS, Ansari Nagar

South
DELHI
110049
India 
Phone  9650638722  
Fax    
Email  drashutoshmishra11@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR GAJENDRA PANDIT 
Designation  SENIOR RESIDENT 
Affiliation  BRAIRCH AIIMS, New Delhi 
Address  1st floor, Department of surgical onclogy, BRAIRCH-AIIMS, Ansari Nagar

South
DELHI
110049
India 
Phone  9650638722  
Fax    
Email  gpandit113@gmail.com  
 
Source of Monetary or Material Support  
Department of surgical onclogy, BRAIRCH-AIIMS, Ansari Nagar, New Delhi, 110049, India  
 
Primary Sponsor  
Name  AIIMS NEW DELHI 
Address  BRAIRCH-AIIMS NEW DELHI 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR GAJENDRA PANDIT  BRAIRCH-AIIMS  Room no. 244, Department of surgical oncology, Ansari Nagar
South
DELHI 
9471166594

gpandit113@gmail.com 
DR GAJENDRA PANDIT  NCI-AIIMS  D wing, 2nd Floor, Department of surgical oncology OPD Block, Badsa
Jhajjar
HARYANA 
9471166594

gpandit113@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institute ethics committee for post graduate research, AIIMS  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Prepectoral implant based breast reconstruction  Implant-based breast reconstruction post mastectomy in which placing the implant above the chest muscle (prepectoral) and follow up the patient on days 10, 30, 60, and 90 days post-surgery to see post operative outcomes including wound dehiscence, hematoma, seroma, infection, mastectomy skin necrosis, loss of implant, implant exposure/extrusion, animation deformity, and capsular contraction, and quality of life. 
Intervention  Subpectoral implant based breast reconstruction  Implant-based breast reconstruction post mastectomy in which placing the implant below the chest muscle that is below pectoralis major muscle (subpectoral) and follow up the patient on days 10, 30, 60, and 90 days post-surgery to see post operative outcomes including wound dehiscence, hematoma, seroma, infection, mastectomy skin necrosis, loss of implant, implant exposure/extrusion, animation deformity, and capsular contraction, and quality of life. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Female 
Details  ECOG 0 and 1
Patient undergoing mastectomy for breast cancer and risk reducing surgery
Presumptive adequate skin flap thickness greater than 8mm on mammogram
Patient should be well oriented and coherent
Both unilateral and bilateral breast surgery cases will be included

 
 
ExclusionCriteria 
Details  Patients with intraoperatively inadequate skin flaps
Metastatic/Recurrent Breast cancer
Pregnant or lactating women
Patient refused for consent for the study.
 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
To compare the overall postoperative outcomes of implant-based breast reconstruction between prepectoral and subpectoral surgical techniques   10th day, 30th day, 60th day, and 90th day 
 
Secondary Outcome  
Outcome  TimePoints 
To compare between the 2 groups mentioned above:

1. Quality of life assessed by using BREAST-Q Version 2.0

2. Length of hospital stay.

 
2 years 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   14/10/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

In India, there is significant variability in breast reconstruction practices. This underscores the need for randomized clinical trials to methodically assess postoperative outcomes and quality of life associated with prepectoral and subpectoral implant-based breast reconstruction techniques.

 
Close